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The movement of melanosomes from post-Golgi
compartments to the periphery of melanocytes is
known to be regulated by factors including myosin
Va and at least one Rab protein, Rab27a. Mutations
in the genes encoding either protein in the mouse
result in a hypopigmented phenotype mimicking the
human disease Griscelli syndrome. Rab27b and
Rab27a share 72% identity and they belong to the
same melanocyte/platelet subfamily of Rab proteins.
Rab27a orchestrates the transport of melanosomes
by recruitment of the actin motor, myosin Va, onto
melanosomes. By contrast, the function of Rab27b
has remained elusive. In this study, we found that
Rab27b mRNA is present in melanocytes and dem-
onstrated the intrinsic GTPase activity of Rab27b
protein. We explored the function of Rab27b by
overexpression of two dominant negative mutants as
well as the wild-type Rab27b in melan-a melano-
cytes. Green-¯uorescent-protein-tagged Rab27b
colocalizes with the melanosome marker tyrosinase-
related protein 1 and with myosin Va at the cell per-
iphery, whereas Rab27b mutants do not decorate
melanosomes, and melanosomes in these mutant
transfected cells redistribute from cell periphery to
the perinuclear region. Furthermore, transient over-
expression of the dominant negative forms of
Rab27b caused diminution in both numbers and
length of dendrites of melan-a cells. Our results sug-
gest that Rab27b may regulate the outward move-
ment of melanosomes and the formation or
maintenance of dendritic extensions in melanocytes.
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ab proteins belong to a large family of small,
membrane-associated GTPases; about 60 mamma-
lian members in this family have already been
identi®ed (Pereira-Leal and Seabra, 2000; Bock et
al, 2001). Rab proteins may coordinate diverse
cellular functions, including signal transduction, cytoskeletal
organization, as well as the regulation of vesicular traf®c and fusion
in eukaryotic cells (Pfeffer, 1999; Zerial and McBride, 2001). These
GTPases have been found to be associated with the cytoplasmic
surface of distinct organelles, and with vesicles mediating transport
between them. Speci®cally, Rab proteins are thought to be
intimately involved in the process of docking and/or fusion of
vesicles with their correct acceptor compartments. Regulation of
speci®c targeting of vesicles by Rab proteins may occur at different
stages of this transport process. First, Rab proteins may recruit
factors involved in the biogenesis of the vesicles or they may
mediate the tethering of motor molecules to the vesicle
(Woodman, 1998). Rab proteins may also affect the targeting of
vesicles to their appropriate destinations by interacting with Rab
effector molecules that may mediate the interactions with
cytoskeletal elements. For example, Rab6 mediates vesicle migra-
tion along the microtubular cytoskeleton, employing Rabkinesin-6
as the motor (Echard et al, 1998). Rab3 has also been shown in vitro
to interact with a-actinin through its effector Rabphilin-3A
(Arribas et al, 1997). These results raise the intriguing possibility
that Rab proteins regulate vesicle interactions with the cytoskele-
ton, thereby playing an active role in membrane traf®cking (Pfeffer,
1999). Rab proteins may also tether vesicles to speci®c components
at the fusion site via Rab-interacting molecules. Rabaptin-5, EEA1,
and Rabenosyn-5 are effectors associated with Rab5. Through
simultaneous or sequential interactions of these docking or
membrane-tethering molecules with Rab5, they orchestrate vesicle
fusion (Horiuchi et al, 1997; Callaghan et al, 1999; Christoforidis et
al, 1999; Nielsen et al, 2000). It was also shown that, once a vesicle
has become tethered to its fusion site, Rab proteins may selectively
activate the SNARE fusion machinery by removing the negative
regulator Munc18 or n-Sec1 from the t-SNARE (Zhang et al,
2000), allowing the free t-SNARE to form the triple-helical spindle
required for vesicle fusion (Lin and Scheller, 2000).
Rab proteins can be further subdivided into two families: one
comprises the ``housekeeping'' Rab proteins, which are expressed
in most cells and regulate basic vesicular transport common to all
mammalian cells, like Rab5 regulating endosome transport
(Woodman, 2000); the other includes speci®c Rabs, which are
expressed in highly differentiated cells that carry out specialized
functions. The restricted tissue distribution of certain Rab proteins
may re¯ect speci®c requirements for the organization of membrane
traf®c in these cells. For example, the unique expression or
enrichment of Rab37 in the MC-9 mast cell line and bone marrow
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cells suggests that Rab37 plays an important role in mast cell
degranulation (Masuda et al, 2000). It appears that Rab27b may also
belong to the group of Rabs that are selectively expressed in highly
specialized cells.
Rab27b was originally isolated from human melanoma cells and
melanocytes (Chen et al, 1997). Melanocytes are specialized cells in
the skin and eye that express a unique elliptical membrane bounded
organelle, the melanosome, which contains speci®c enzymes
involved in melanin biosynthesis. Melanosomes contain an internal
matrix upon which insoluble melanins are deposited. Based on
morphologic studies, melanosomes have been described as under-
going four stages of development, namely, stage I and stage II
premelanosomal compartments, partially melanized stage III
melanosomes, and fully melanized stage IV melanosomes. Early
models for melanosome biogenesis suggested that immature,
endoplasmic-reticulum-derived organelles fuse with trans-Golgi
network (TGN)-derived vesicles containing melanogenic
components such as tyrosinase and TRP1/gp75 to form melano-
somes (Quevedo et al, 1987; Orlow, 1998). Recent studies have
suggested the alternative possibility that stage I premelanosomes are
TGN-derived coated endosomes (Jimbow et al, 2000; Raposo et al,
2001). Pmel17 (gp100/silver locus protein) is the ®rst well-
characterized melanosomal protein that appears in early stage
melanosomes (Kobayashi et al, 1994). Other melanogenic enzymes
such as tyrosinase and TRP1 are added subsequently.
Melanosomes move bidirectionally along microtubules. At the
cell periphery, myosin Va links melanosomes to the subcortical
actin ®laments in the dendritic extensions of melanocytes (Wu et al,
1997) from which the melanosomes are taken up by recipient cells
such as neighboring keratinocytes or are inserted into nascent hair
shafts.
Recent studies have shown that melanosome transport in
melanocytes is highly regulated by Rab27a (Wilson et al, 2000;
Hume et al, 2001; Wu et al, 2001). Truncation of the RAB27A
gene results in the phenotype of ashen mice and has been implicated
in Griscelli syndrome (GS, MIM 214450). GS is a rare autosomal
recessive disorder that results in pigmentary dilution of the skin and
hair, the presence of large clumps of pigment in hair shafts, and an
accumulation of melanosomes in the perinuclear region of
melanocytes. Rab27a and myosin Va were both mapped to the
GS locus at chromosome 15q21 but they are 1.6 cM apart from
each other (Westbroek et al, 2001). The phenotype of melanocytes
in Rab27a-de®cient ashen mice resembles that of melanocytes from
myosin-Va-de®cient dilute mice; they both fail to capture
melanosomes in the cell periphery, resulting in the accumulation
of mature melanosomes in the perinuclear region. Overexpression
of the GTP-bound form but not the GDP form of Rab27a in ashen
melanocytes rescued this defect. In addition, without functional
Rab27a, myosin Va in ashen melanocytes does not colocalize with
melanosomes (Wu et al, 2001). It thus seems that Rab27a recruits
myosin Va to the melanosome and that myosin Va then tethers the
melanosomes to subcortical actin ®laments at the periphery of the
cell. A direct interaction between Rab27a and myosin Va was
recently shown by Hume et al (2001) employing coimmunopre-
cipitation.
Although mutations of either Rab27a or myosin Va produce the
same phenotype of lightened coat color, they de®ne two distinct
subfamilies of GS. Patients with the RAB27A gene defects
developed a hemophagocytic syndrome and Rab27a-de®cient T
cells exhibited reduced cytotoxicity and cytolytic granule exocy-
tosis required for immune homeostasis (Menasche et al, 2000). The
single Turkish patient with a myosin Va mutation, however,
exhibited primary neurologic impairment without immune defects
(Pastural et al, 1997), whereas Rab27a-de®cient mice did not
demonstrate any neurologic defect. These differences suggest that
Rab27a may not be the sole partner of myosin Va.
Sequence comparison with known Rabs indicates that Rab27a
and Rab27b proteins comprise a melanocyte/platelet subfamily
within the Rab family (Pereira-Leal and Seabra, 2000). The
expression of Rab27a and Rab27b in both melanocytes and
platelets makes them candidates for involvement in mouse and
human disorders characterized not only by the combination of
pigment dilution and a platelet storage pool defect, but also with
immunologic defects (Haddad et al, 2001). Despite the fact that
Rab27b is the Rab protein most closely related to Rab27a, little
new information emerged as it was cloned (Chen et al, 1997). The
gene encoding human Rab27b was recently mapped to chromsome
18q21.1 (Ramalho et al, 2001), rather than chromosome 15 where
Rab27a is located (Tolmachova et al, 1999). As these two highly
homologous Rab proteins exhibit rather selective expression
patterns, it is possible that they also possess functional overlap.
On the other hand, Rab27b may also have a unique function
because it cannot complement the ashen phenotype (Wilson et al,
2000). Here, we report on the tissue distribution of Rab27b in
comparison with that of Rab27a by reverse transcription
polymerase chain reaction (RT-PCR). The mRNA of Rab27b
was present in melan-a cells and the protein was associated with
melanosomes. Dominant negative forms of Rab27b do not
associate with melanosomes. Overexpression of dominant-negative
mutants of Rab27b not only caused redistribution of melanosomes
from the cell periphery to the perinuclear region but also caused a
diminution of dendrites in melan-a cells. Our results suggest that
Rab27b may also play an important role in dendrite extension and
in melanosome transport.
MATERIALS AND METHODS
Cell lines and antibodies Melan-a cells, cultured melanocytes from
nonagouti black C57BL/6 J mice, were obtained from Dr. D. C.
Bennett (St. George's Hospital, London, U.K.), and maintained as
described previously (Bennett et al 1987). The antiserum aPEP1 raised
against tyrosinase-related protein 1 (Tyrp1) was from Dr. V. J. Hearing,
National Cancer Institute, Bethesda, MD (JimeÂnez et al 1991). The
antiserum Dil2 against mouse myosin Va (Wu et al, 1997) was provided
by Dr. John Hammer Jr. (National Heart, Lung and Blood Institute,
Bethesda, MD). The sera were used in experiments without further
puri®cation. The rat monoclonal antibody 1D4B against murine
lysosome-associated membrane glycoprotein 1 (Lamp1) (Hughes and
August, 1981) was from the Developmental Studies Hybridoma Bank
(University of Iowa, Iowa City, IA).
Plasmids construction Cloning procedures were performed according
to standard methods (Maniatis et al, 1982). Enzymes and buffers were
purchased from Roche (Nutley, NJ), Gibco (Gaithersburg, MD), or
from New England Biolabs (Beverly, MA). The cDNA of bovine
Rab27b was originally obtained by screening a bovine urothelium
library, which was generated by Dr. Fang-Ming Deng in Dr. Tung-Tien
Sun's laboratory (New York, NY). The coding region was cloned into
pcDNA3.0 vector. Mutant forms of Rab27b, Rab27b-N133I, and
Rab27b-Y29L were generated by PCR site-directed mutagenesis.
Constructs were sequenced by the NYU DNA sequencing facility
(Skirball Institute, New York, NY).
In order to purify Rab27b for in vitro GTPase assays, Rab27b and its
mutant forms were cloned into the pMALC2 vector (a gift from Dr.
Mindong Ren, NYU, New York, NY) between the EcoR I and Sal I
sites. The resulting plasmids encode fusion proteins that contain each
Rab protein or its mutants attached to the C-terminus of the maltose
binding protein, abbreviated MBP-Rab27b, MBP-N133I, and MBP-
Y29L. Similarly, for the expression assay, Rab27b and its mutant forms
were cloned into pEEGFPC2 vector (Stratagene, La Jolla, CA) between
the EcoR I and Apa I sites. The resulting plasmids encode fusion
proteins that contain each Rab protein or its mutants attached to the C-
terminus of the enhanced green ¯uorescent protein, abbreviated EGFP-
Rab27b, EGFP-N133I, and EGFP-Y29L.
RNA isolation RNAs were isolated from 1±3 g of fresh tissue:
urothelium scraped from bovine bladders or cultured cells from three
plates (10 cm diameter) following the standard protocol (Gilman, 1997).
The optical density at 260, 230, and 280 was measured to determine the
amount and purity of the total RNA. Ratios of A260/A230 > 1.7 and
A260/A280 > 1.7 were obtained. Intactness of the mRNA was inferred
by intactness of 18S and 28S ribosomal RNA, as visualized on RNA
agarose gels described in the next section.
RT-PCR The ®rst-strand cDNAs for the PCR reaction were
synthesized from »25 ng of total RNA of each tissue per reaction using
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the AMV reverse transcriptase (Promega Cat. No. 3500). PCR was
carried out using a PWO DNA polymerase (Roche, Nutley, NJ).
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a
control to determine the amount of cDNA templates and the numbers
of cycles within a linear range. The optimized cycle pro®le for Rab27a
and Rab27b was one cycle, 94°C, 3 min; 25 cycles, 94°C, 1 min; 58°C,
45 s; 72°C, 1 min; one cycle, 72°C, 7 min. Primers for Rab27a and
Rab27b PCR were 27a-forward, 5¢-GCCACCATGTCCGAAACTG-
GATAAGCCAGC-3¢; 27a-reverse, 5¢-TCA AAG ATC TTA ATG
TCT TCA ATG AGA C-3¢; 27b-forward, ATGACCGATGGGGAC-
TATGATTATCTG; 27b-reverse, 5¢GGAGAAGTCAGCAGAGAAGA-
AATGTGC-3¢.
Site-directed mutagenesis Mutated forms of bRab27b were
constructed using a point mutagenesis PCR kit from Stratagene (La Jolla,
CA). PCR cycles used were 12 cycles for a single base change and 16
cycles for two or three bases change for an amino acid change: 94°C,
1 min; 55°C, 1 min; 68°C, 2 min, for each 2 kb plasmid. Primers used
to generate each mutant are as follows: N133I (no GTP/GDP binding,
397±399: AAC-ATC) forward, 5¢-GTA TTA ATT GGC ATC AAG
GCA GAC CTG CC-3¢; reverse, 5¢-GG CAG GTC TGC CTT GAT
GCC AAT TAA TAC-3¢5¢-GG CAG GTC TGC CTT GAT GCC
AAT TAA TAC-3¢; Y29L (85±87: TAC-TTG) forward, 5¢-AAG ACA
ACA TTT CTT TAT CGA TTG ACA GAC-3¢; reverse, 5¢-GTC
TGT CAA TCG ATA AAG AAA TGT TGT CTT CCC-3¢.
After the PCR, 1 ml of 5 U per ml of Dpn I restriction enzyme was
added to each 50 ml PCR reaction and incubated at 37°C for 1 h to
digest the circular plasmid template. 1 ml of the PCR-generated
linearized plasmids was used to transform 50 ml of XL-1-blue cells
(competency 1012 colonies per mg DNA). A single colony was inoculated
on the second day for mini prep, followed by restriction enzyme
digestion or sequencing to con®rm the designed point mutation.
Puri®cation of MBP fusion proteins Escherichia coli transformants
containing MBP fusion plasmids were generated as described above. For
puri®cation, a 5 ml culture in LB containing ampicillin (50 mg per ml)
was inoculated from the frozen stock and grown to saturation overnight
at 37°C. The overnight cell culture was diluted into 1000 ml of medium
in a 2 liter ¯ask and grown under antibiotic selection at 37°C to an
OD of 0.6 (2±4 h). IPTG was added (0.5 mM ®nal) and the culture was
grown at 37°C for an additional 3 h. After centrifuging the cell culture
for 15 min, 3000 rpm at 4°C, the supernatant was decanted and the
pellets were collected in a total of 10 ml of phosphate-buffered saline
(PBS) containing 1 mM ethylenediamine tetraacetic acid (EDTA), 5 mg
per ml aprotinin, and 1 mM phenylmethylsulfonyl ¯uoride, and were
transferred to a 50 ml tube containing an equal volume of binding buffer
pH 7.0 [10 mM NaPO4 buffer pH 7.2, 0.5 M NaCl, 1 mM sodium
azide, 10 mM b-mercaptoethanol, 10 mM EDTA pH 8.0, and 10 mM
ethyleneglycol-bis(b-aminoethyl ether)-N,N,N¢,N¢-tetraacetic acid].
After sonication, 5 ml of amylase resin was washed three times with the
binding buffer and added to the supernatant mixing followed by rotation
for 2 h at 4°C. To elute MBP fusion proteins, the amylase resin was
collected by centrifugation (1±2 min, 2000 rpm) and washed three times
with binding buffer. 3 ml of 10 mM maltose in the binding buffer was
added to 2 ml of resin and mixed by inverting. Usually 1±2 mg per ml
of puri®ed protein were obtained (determined by Bradford assay), and
stored at 4°C for up to 1 mo. For long-term storage at ±70°C, the
protein concentration was increased to 4 mg per ml by adding bovine
serum albumin (BSA).
GTP ®lter binding assay Four micrograms of puri®ed MBP-Rab27b
or its mutants were incubated at 25°C for 10 min with 1.0 mCi of
[a-32P]-GTP in 200 ml of a buffer containing 25 mM Tris±HCl,
pH 7.5, 25 mM NaCl, 2 mM EDTA, 1 mM dithiothreitol (DTT), and
200 mg per ml BSA. MgCl2 was added to a ®nal concentration of
10 mM and the solution was then diluted with 1 ml of 25 mM Tris±
HCl, pH 7.5, 25 mM NaCl, 10 mM MgCl2 before passage through a
nitrocellulose ®lter. The ®lter was then washed with 30 ml of the same
dilution buffer and air dried, and the radioactivity retained in the ®lter
was counted in a scintillation counter. This ®lter-binding assay allowed
us to measure the GTP binding ability of proteins. The molar ratio of
protein versus GTP re¯ects the native GTP binding capability of the
GTPase because the protein retains its native conformation throughout
the reaction.
GTP hydrolysis assay The determination of the GTPase activity is
complicated by the fact that three different reactions affect the amount of
[g-32P]-GTP bound to the Rab protein. In addition to the real enzyme
activity, which hydrolyzes GTP to GDP and releases free unlabeled
phosphate, there are the intrinsic GTP falling-off rate and the GTP/
GDP exchange rate that cannot be ignored in the reaction system, even
in the absence of GTP exchange factors. The ®lter-binding assay can
measure the amount of GTP initially loaded, but it cannot distinguish
between GTP hydrolysis versus exchange or off-rate. Therefore, charcoal
was used to absorb proteins and nucleotides, thus enabling us to monitor
the released free g-32P.
Thirty micrograms of puri®ed Rab27b or its mutants were incubated
at 25°C for 10 min with 1.0 mCi [g-32P]-GTP in 200 ml of a buffer
containing 25 mM Tris±HCl, pH 7.5, 25 mM NaCl, 2 mM EDTA,
1 mM DTT, and 200 mg per ml BSA. MgCl2 was added to a ®nal
concentration of 10 mM. At different time intervals, equal aliquots of the
reaction mixture (»4 mg GTPase) were withdrawn and mixed with
0.5 ml of a cold 2% wt/vol charcoal suspension in 25 mM Tris±HCl,
pH 7.5, 25 mM NaCl, 10 mM MgCl2. Fifty microliters of each
supernatant was counted after sedimentation of the charcoal.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) Samples were normally boiled in the sample buffer containing
0.1 M DTT or 0.1 M b-mercaptoethanol before loading. For
nonreducing gels, samples were boiled in the sample buffer without
adding reducing reagent. Pre-stained protein molecular weight standards
were obtained from Gibco/BRL (Gaithersburg, MD). Samples were then
separated on 17% acrylamide gel and stained by 0.2% Coomassie Brilliant
Blue R250 (Bio-Rad, Hercules, CA).
Immuno¯uorescence cell staining Melan-a cells were seeded on
glass coverslips in 24 well plates containing 0.5 ml medium per well or
60 mm tissue culture dishes containing 5 ml medium per dish. After 22±
24 h, the cells were transfected with the plasmid containing the Rab27b
coding sequence fused at its N-terminus with GFP sequence (EGFP-
Rab27b). The transfection was performed using FuGene 6 transfection
reagent (Roche, Indianapolis, IN) at a transfection ef®ciency of 10%
with FuGene:DNA ratio 3:1 and DNA concentration 0.4 mg per ml
culture medium as suggested by the manufacturer. 22±24 h following
transfection, coverslips were rinsed with ice-cold PBS, ®xed in ±20°C
methanol for 5 min, and air-dried. The coverslips were then blocked for
1 h in 5% goat serum in PBS, and incubated 1 h at 37°C in the primary
antibody diluted in the blocking solution. They were then washed six
times with 0.5% goat serum in PBS. The cells were blocked again for
30 min, and incubated for 1 h with Alexa-546-labeled secondary
antibody (Molecular Probes, Eugene, OR). Coverslips were washed six
times with 0.5% goat serum in PBS, rinsed with water, and mounted in
ProLong Antifade (Molecular Probes). Images were acquired using the
Zeiss LSM510 confocal system or with a Zeiss Axiovert 100 M
microscope. Images were processed using LSM510 software and Adobe
Photoshop 3.0.
Assessment of dendrite extensions in melan-a cells Melan-a
melanocytes were transfected with EGFP-Rab27b or its mutant forms,
whereas nontransfected cells were immunostained with the melanosome
marker TRP-1. This allowed us to recognize the dendritic extensions
under the ¯uorescence microscope as the mutant forms ®ll the entire
cytosol. Images were systematically scanned from the left to the right
of a coverslip in a meandering (S) pattern. First 18 well-stained
nontransfected cells were selected for analysis. In a similar fashion, cells
transfected with one of the GFP-Rab27b fusion proteins were randomly
selected for assessing the changes in cell shape. The length and number
of dendrites in each type of transfected melanocytes were assessed using
the Zeiss LSM 510 software. Cellular extensions ®tting the following
criteria were counted as a dendrite: longer than 2 mm and not wider
than 2 mm at the base. The histogram of Fig 5 was generated using the
CA-cricket III software.
RESULTS
Tissue distribution of Rab27a and Rab27b Because of the
close sequence similarities between Rab27a and Rab27b, we ®rst
asked if the tissue expression pattern of Rab27b is similar to that of
Rab27a. Although Rab27a and Rab27b share about 72% amino
acid sequence similarity, RT-PCR analysis reveals that they have
distinct tissue distributions. GAPDH (panel C) was used as control
to ensure that the PCR ampli®cation was within the linear range.
Rab27a (panel A) and Rab27b (panel B) gene speci®c primers were
designed according to the sequence of the mouse Rab27a gene
(gene bank NM_023635) and a mouse Rab27b gene generated
previously by 5¢ and 3¢ RACE reaction (gene bank AY 010898).
The previously cloned Rab27b plasmid was used as the negative
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control for Rab27a primers and the sequenced Rab27a PCR
product was used as negative control for Rab27b primers. Rab27a
primers ampli®ed from Rab27a cDNA (panel A, lane 2), but not
from Rab27b cDNA (panel A, lane 1). Rab27b primers ampli®ed a
product of expected size from Rab27b template (panel B, lane 2),
but not from Rab27a template (panel B, lane 1). The annealing
temperature for the PCR reaction was optimized for each pair of
primers. Plasmids containing mRab27a, mRab27b, or GAPDH
cDNA were used as positive controls (PC). As shown in Fig 1,
both Rab27a and Rab27b were detected in most of the tissues
tested, including bladder, kidney, melan-a cells, and spleen, but
they were not detectable in muscle or liver. In certain tissues,
however, distinct differences between Rab27a and Rab27b
expression were observed: for example, only Rab27a mRNA was
found in lung, whereas Rab27b is easily detected in whole brain.
Point mutations alter the GTP binding capacity of Rab27b
in vitro In order to study the function of Rab27b in melanocytes,
we designed two mutated forms with point mutations chosen
Figure 1. Tissue distribution of mouse Rab27a and mouse
Rab27b as determined by RT-PCR. Total RNA was isolated from
the following mouse tissues and cells: bladder, brain, kidney, liver, lung,
melan-a cells, muscle, spleen, and stomach. The Rab27b plasmid was
used as a negative control for the PCR ampli®cation with Rab27a-
speci®c primers (A, lane 1); Rab27a cDNA was used as a negative
control for the PCR ampli®cation with Rab27b-speci®c primers (B, lane
1). As a negative control, the GAPDH PCR reaction contained no
template (C, lane 1). Rab27a cDNA con®rmed by sequencing or
plasmids containing mRab27b or GAPDH cDNA were used as positive
controls for the gene-speci®c PCR ampli®cation (lane 2). Speci®c
primers were used for Rab27a (A), Rab27b (panel B), and GAPDH (C).
Ten microliters of each PCR reaction was analyzed by agarose gel (2%)
electrophoresis. Mouse Rab27b was expressed in bladder, brain, kidney,
melan-a cells, and spleen. Mouse Rab27a was expressed in bladder, lung,
kidney, melan-a cells, spleen, and stomach.
Figure 2. Puri®cation and biochemical changes of MBP-Rab27b
and its mutants. (A) Puri®cation of MBP-Rab27b and its mutants from
bacteria. The cDNAs encoding a fusion protein of MBP with Rab27b
(MBP-Rab27b), as well as the mutant forms, were expressed in bacteria
and af®nity puri®ed using an amylase resin from Bio-lab (Hercules, CA).
The puri®ed fusion protein fractions were analyzed by SDS-PAGE gel
(17%), followed by Coomassie Blue staining. Cell lysate obtained before
induction with isopropyl b-D thiogalactoside IPTG (lane 1); cell lysate
obtained 3 h after induction with IPTG. As large amounts of MBP-27b
protein are synthesized, 10-fold less sample was loaded for lanes 2, 3, 4,
5, and 6: 40 kDa puri®ed MBP as control (lane 3), 65 kDa puri®ed
MBP-Rab27b (lane 4), puri®ed MBP-N133I (lane 5), and puri®ed MBP-
Y29L (lane 6). (B) Point mutations alter GTP binding capacity of
Rab27b. Four micrograms (0.16 nmol) of each MBP fusion protein of
Rab27b as well as the mutant forms were immobilized on amylase resin
beads and mixed with [g-32P]-GTP, where 1000 cpm corresponds to 9
pmol GTP. The stoichiometry for the wild-type Rab27b is about 0.6
mol GTP per mol GTPase. After a reaction time of 5 min, the MgCl2
concentration was raised from 10 mM to 25 mM in order to prevent the
dissociation of bound GTP. The enzyme-bound GTP was separated
from the unbound GTP by passing the reaction through a nitrocellulose
®lter. The amount of radioactivity remaining on the ®lter represents the
enzyme-bound GTP. MBP served as a negative control. The point
mutation N1133I abolished the GTP binding capacity of Rab27b,
whereas Y29L showed 60% binding compared with the wild-type
protein. The values given in the graph are averages of three independent
experiments. (C)Point mutations alter the GTPase activity of Rab27b.
About 30 mg of the GTPases were mixed at 25°C with reaction buffer
containing 10 mM MgCl2. At the time points indicated, aliquots
corresponding to about 4 mg GTPase were withdrawn and mixed with
600 ml of an ice-cold charcoal suspension (2%). The hydrolyzed 32P,
which was not absorbed by the charcoal, was measured in the
supernatant after sedimentation of the charcoal-containing protein as well
as free radioactive GTP. The N133I form mutant did not show any
GTPase activity because it did not bind any GTP (B). The Y29L mutant
hydrolyzes GTP at a rate similar to that of the wild-type GTPase.
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according to functional studies performed on other Rab proteins.
Rab27b-N133I is a dominant negative Rab mutant that does not
bind GTP or GDP. The effect of the Y29L mutation on a Rab was
recently described in a functional study on Cdc42 (Wu et al, 2000).
The similar Cdc42 mutant was found to have constitutive GTPase
activity in the absence of a guanine nucleotide exchange factor. In
order to compare the intrinsic in vitro GTPase activity of these
mutants with that of the wild-type Rab27b, we expressed MBP
fused with Rab27b or its mutants in bacteria. The proteins were
af®nity puri®ed using an amylase resin (Fig 2A). MBP protein
alone was used as the negative control. As shown in Fig 2(B),
MBP-Rab27b-N133I does not bind any guanine nucleotide,
consistent with previous studies. On the other hand, MBP-
Rab27b-Y29L binds about 60% [g-32P]-GTP compared with the
wild-type Rab27b. This difference in GTP binding may be due to
a lower binding capacity of the Y29L form compared to the wild-
type protein. Alternatively, the binding capacity of Y29L with GTP
is similar to the wild-type, but the Y29L form has a high GTPase
activity due to the fact that exchange of GDP for GTP does not
require speci®c factors or exchange proteins. The GTP binding
assay that tests simply for the steady state level GTP binding did not
distinguish between these two mechanisms.
The kinetics of GTPase activity of Rab27b and its
mutants As may be expected from the ®nding that the N133I
form of Rab27b does not bind GTP (Fig 2B), it lacks signi®cant
GTPase activity (Fig 2C). Overexpression of the N133I mutant
may also affect the proper functioning of the endogenous Rab27b
by depleting cells of binding proteins like GEF or GDI, thus
interrupting the recycling of the wild-type Rab protein. In this way
it functions as a dominant negative mutant. In the other case, the
Y29L mutant hydrolyzes GTP at a rate similar to that of the wild-
type Rab27b in the presence of a ®xed amount of GTP (200 nM)
(Fig 2B). The ®nding that it binds about 60% of GTP compared to
the wild-type Rab27b suggests that the exchange rate of GTP for
GDP is slower, resulting in lower steady state binding levels.
Subcellular distribution of transiently expressed EGFP-
Rab27b in melanocytes As the speci®c mutations in Rab27b
resulted in dramatic changes in the GTPase activity of Rab27b
in vitro, we used these mutants to determine the function of Rab27b
in melanocytes. Melan-a cells are derived from inbred C57BL mice
and they express the whole cycle of melanosome maturation
characteristic of the differentiated state of this cell type.
Melanosomes in these cells contain marker enzymes such as
tyrosinase and Tyrp1 (Bennett et al, 1987). We took advantage of
the Rab27b mutants to determine whether Rab27b functions
in regulating melanosome transport, and whether the mutant
forms of Rab27b could disrupt normal Rab27b function.
Immuno¯uorescence staining was performed on melan-a cells
transiently transfected with wild-type Rab27b with an enhanced
GFP tag at its N-terminus (EGFP-Rab27b). As expected, the
expressed EGFP-Rab27b displayed a granular distribution in
melan-a cells and colocalized with melanin granules and the
melanosomal marker Tyrp1, particularly in the vicinity of the
plasma membrane (Fig 3A±D). The protein also colocalized with
myosin Va, a protein involved in melanosome movement (Fig 3E±
H), and to a lesser extent with the endosomal/lysosomal marker
Lamp1 (Fig 3I±L).
Transient expression of mutant forms of Rab27b result in
the relocation of melanosomes from the cell periphery to
the perinuclear region and diminution of both number and
length of dendritic extensions To ascertain the potential
biologic signi®cance of Rab27b in melanosome translocation, we
also studied the effects of two dominant negative EGFP-Rab27b
mutants N133I and Y29L on melanosome distribution. When
expressed in melan-a cells, both mutants resulted in diffuse
cytoplasmic (both cell body and dendrites) and nuclear
localization of GFP ¯uorescence. They caused melanosomes,
identi®ed by the presence of melanin pigment (Fig 4D, H, L),
and Tyrp1 staining (Fig 4A, E, I) to redistribute to the perinuclear
region of the cell (Fig 4D, H). The effect of Rab27b mutants on
redistribution of melanosomes is incomplete in that only about 80%
of cells exhibited concentration of melanosomes in the perinuclear
area with the remainder of the cells showing a normal pattern of
melanosome distribution. We attribute this to the quantity and
timing of Rab27b mutant expression in transfected cells.
We noticed an apparent effect of Rab27b dominant negative
mutations in dendrite formation by measuring the number and
length of cellular extensions in mutant transfected cells. Taking
advantage of the green ¯orescence emitted from GFP-Rab27b
constructs or the TRP1 stained control cells, we analyzed 18 cells
from each category using immuno¯uorescence microscopy.
Figure 3. EGFP-Rab27b colocalizes with
melanosomes but not lysosomes. Transiently
expressed Rab27b protein colocalizes with
melanin granules decorated by Tyrp1 and myosin
Va, and to a lesser extent with lysosomes
decorated by Lamp1. Melan-a cells were
transfected with a plasmid encoding wild-type
Rab27b protein fused at its C-terminus to GFP.
22±24 h post-transfection, all cells were ®xed with
methanol, and stained for Tyrp1 (A), myosin Va
(E), and Lamp1 (I) as described in Materials and
Methods. (B), (F), and (J) show GFP-Rab27b
¯uorescence of the same cell shown in the panels
to the left. (C), (G), and (K) are merged images,
and (D), (H), and (L) are phase contrast images of
the cells shown in the same row. Scale bar: 10mm.
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Although the shapes of melan-a cells are naturally heterogeneous,
we have found that the total number of dendrites in cells transfected
with wild-type Rab27b (69 dendrites per 18 cells) increased 60% in
comparison with nontransfected cells (44 dendrites). Furthermore,
the number of very long (> 45 mm) dendritic extensions tripled in
melan-a cells transfected with wild-type Rab27b compared to the
nontransfected cells (Fig 5). In contrast, the total number of
dendrites decreased to 38 in cells transfected with the dominant
negative mutant N133I (»10%) and to 33 when Y29L was
expressed (»25%). Moreover, not only did the peak length of
dendrites shift to 2±5 mm in N133I and 5±15 mm in Y29L,
respectively, but also no dendrites longer than 25 mm were
observed in either type. To avoid missing any ``invisible'' dendrites
due to the lack of melanosomes within the dendrites, a number of
precautions were taken. For the wild-type Rab27b transfected or
nontransfected cells we measured dendrites under phase and
immunostaining with TRP1. As the GFP-Rab27b mutants are
cytosolic and hence evenly distributed in both dendrites and the
cell body, we measured dendrites in those cells by immuno¯uor-
escence.
DISCUSSION
Of the two Rab27 family members identi®ed to date, only Rab27a
has been assigned a cellular function, namely, melanosome
traf®cking. Although transient expression of EGFP-Rab27b in
melanocytes showed colocalization with melanosomes (Ramalho et
al, 2001; Westbroek et al, 2001), the function of Rab27b is
unknown. As an initial step to understand its function we studied
wild-type Rab27b and two of its dominant negative mutants. RT-
PCR analysis showed that Rab27b was expressed in a number of
tissues including bladder epithelium, brain, kidney, spleen, and in a
cultured mouse melanocyte line, melan-a cells. Rab27a was
expressed in bladder, kidney, lung, spleen, stomach, testis, and
melan-a cells. The expression of Rab27b in melan-a cells was
further con®rmed by sequencing the ampli®ed cDNA fragment.
This ®nding agrees with the fact that the cDNA of Rab27b was
originally cloned from melanocytes (Chen et al, 1997). In a recent
report, however, Ramalho et al (2001) did not detect Rab27b in
melan-a cells by RT-PCR. This discrepancy may arise from
different experimental conditions employed in RT-PCR analyses,
the speci®city of primers, and/or the status of the cultured cells.
The current model for melanosome traf®cking assumes a two-
step process, namely, long-range bidirectional movement of
melanosomes along microtubules and capture of the melanosomes
by a random matrix of actin ®laments in the cell periphery (Wu et
al, 1998). It has been shown that defective Rab27a is one of the
causes of diminished pigmentation in GS and in ashen mice
(Menasche et al, 2000). Hume et al (2001) showed that Rab27a
Figure 4. EGFP-Rab27b-N133I and EGFP-
Rab27b-Y29L disrupt melanosome traf®cking
to the cell periphery. Melan-a cells were
transfected with a plasmid encoding the Rab27b
mutant form N133I (A±D) or Y29L (E±H) fused
at its C-terminus to GFP. 24 h after transfection,
all cells were ®xed with methanol, and stained for
Tyrp1. In untreated controls (I, G, K, L), Tyrp1
(I)staining and melanin distribute to the periphery
of nontransfected cells. The red staining patterns
(A)and (E) were obtained by immunostaining
with antibody against Tyrp1. The green
¯uorescence corresponds to EGFP-Rab27b-N133I
(B) and EGFP-Rab27b-Y29L (F). The merged
images (C) and (G) showed no colocalization of
Tyrp1 with the Rab27b mutant protein. Phase
contrast images (D, H) demonstrate the melanin
distribution in cells transfected with the Rab27b
mutants. Over-expression of the dominant
negative mutants, N133I and Y29L, causes
melanin granules and Tyrp1 to redistribute to the
perinuclear area of melan-a cells. Scale bar: 10mm.
Figure 5. Overexpression of Rab27b mutants causes a diminution
of dendrite number and length in melan-a cells. Transfection and
staining of melan-a cells were carried out following procedures described
in Fig 4 and Materials and Methods. The length and width at the base of
each dendrite was measured using the Zeiss LSM 510 software as
described in Materials and Methods. Melan-a cells transfected with wild-
type Rab27b have a broad distribution in the length of dendrites ranging
from 2 mm to 45 mm, and a signi®cant increase in the number of very
long dendrites (>45 mm) was observed compared to the nontransfected
cells. In contrast, cells transfected with dominant negative mutant
constructs do not exhibit dendrites longer than 25 mm. The peak length
of dendrites in cells transfected with the N133I construct was shortened
to the range 2±5 mm.
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regulated melanosome traf®cking in melanocytes and suggested that
it might function to recruit myosin Va, a molecular motor, onto
melanosome membranes. Previous studies (Chen et al, 1997;
Ramalho et al, 2001) as well as our analysis reported here
demonstrate broad tissue distribution of Rab27a and Rab27b
proteins. As overexpressed Rab27b, similar to Rab27a, is capable of
associating with melanosomes, it is likely that Rab27b executes
Rab27a-like functions in other tissues, presumably through myosin
Va. A distinct difference between certain dilute mouse mutations
and the ashen mouse is that, in the former, severe neurologic defects
are observed, whereas these defects are absent in the latter. This
phenotype could be due to very low expression levels of Rab27a.
Alternatively, Rab27a may be expressed only in specialized areas of
brain and was therefore not detected on a northern blot of whole,
unfractionated brain (Chen et al, 1997; Ramalho et al, 2001).
Furthermore, dilute lethal mice develop ataxia after 10 d of postnatal
life. Abnormal tyrosine hydroxylase expression can be detected in
the Purkinje cells of the cerebellum before the onset of ataxia and
the extensions of the endoplasmic reticulum in the dendritic spines
of these cells is missing (Dekker-Ohno et al, 1996; Sawada et al,
1999). Our data demonstrate that dominant negative forms of
Rab27b cause a redistribution of melanosomes to the perinuclear
area of melanocytes and a reduction both in numbers and in length
of dendritic extensions. Given the 72% homology between Rab27a
and Rab27b, it is possible that the dominant negative effects of
overexpressed Rab27b mutants arise from other intracellular
processes, perhaps indirectly through consumption of Rab27a
binding proteins functioning in the Rab cycle. It is more likely,
however, that Rab27b may regulate melanosome movement via
myosin Va independently of Rab27a. This argument is based on
the following observations. (i) Transient overexpression of Rab27b
dominant negative mutants caused diminution of both numbers
and length of dendrites. These phenomena were not observed in
Rab27a-de®cient melanocytes (Wu et al, 2001). (ii) The presence
of Rab27b mRNA in brain can explain the neurologic defects
observed in dilute mice. The overexpression of dominant negative
mutants of Rab27b does not distinguish between a mechanism that
prevents the formation of dendritic extension or one that causes
existing dendrites to retract. Conceivably, Rab27b is crucial in
directing the movement of melanosomes towards the cell periph-
ery. This may be accomplished by organizing the actin ®lament
with the help of myosin Va at the cell periphery.
We also speculate that defective Rab27b function may be the
secondary cause of choroideremia (CHM), a retinal degenerative
disease, classi®ed under the broad grouping of retinitis pigment loss.
The direct cause of CHM is deletions in REP-1, which is involved
in the selective prenylation of Rab27a (Casey and Saeabra, 1996).
Thus unprenylated Rab27a was originally thought to be the
secondary cause of CHM. This explanation can be ruled out,
however, because in the Rab27a-de®cient mouse model ashen eye
color was normal. This suggests that CHM may be due to a lack of
prenylation of a different gene product, quite possibly Rab27b,
which shares the same Rab escort protein (REP-1) with Rab27a.
Given the broad tissue distribution of Rab27a and Rab27b, it is
also likely that they may function in nonmelanocytic cells to direct
the traf®cking of melanosome-like organelles including secretory
lysosomes and related organelles (Orlow, 1998). In this study, we
observed that expressed Rab27b partially colocalizes with the
lysosomal protein Lamp1. Similarly, Hume et al (2001) observed
partial colocalization of Rab27a with Lamp1 in melanocytes.
Further evidence for interaction between Rab27a and lysosome-
like organelles comes from GS and ashen mice. In both cases, the
mutations in Rab27a cause defects in the function of hematopoietic
cells (Wu et al, 1998; Menasche et al, 2000; Wilson et al, 2000). No
condition involving mutations in Rab27b has been identi®ed to
date. It may be that the effect of Rab27b mutations is so subtle that
it may simply have gone unnoticed or that Rab27b acts in a critical
pathway in certain tissues such that any mutation that results in a
defective Rab27b is lethal. Further studies on Rab27b are needed
to address remaining questions pertaining to its function.
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